Sodium Valproate as an Adjunctive Drug in Treatment of Schizophrenia
| Author | Victoria Omranifard | en |
| Author | Afsaneh Karbasi Amel | en |
| Author | Siamak Amanat | en |
| Issued Date | 2007-01-30 | en |
| Abstract | Objective: Although sodium valproate came to the market as an anticonvulsant drug, nowadays it's wildly used in the management of psychiatric disorders. It is used as a mood stabilizer and as an adjunctive agent in treatment of depression and psychosis. There are controversies regarding sodium valproate efficacy in psychosis. Although some studies have reported that it is effective in the management of positive symptoms and aggression in acute psychosis, others have not found such an association. Our study aims to investigate the effects of adjunctive sodium valproate in the pharmacological management of patients with schizophrenia. | en |
| DOI | https://doi.org/ | en |
| URI | https://brieflands.com/journals/ijpbs/articles/2700 | en |
| Keyword | Risperidone | en |
| Keyword | Schizophrenia | en |
| Keyword | Valproic Acid | en |
| Publisher | Brieflands | en |
| Title | Sodium Valproate as an Adjunctive Drug in Treatment of Schizophrenia | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- ijpbs-v1n1p12-en.pdf
- Size:
- 60.23 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF